Muscle mass and outcomes of critically ill patients
Not Applicable
Recruiting
- Conditions
- Patients admitted in the IC
- Registration Number
- JPRN-UMIN000039754
- Lead Sponsor
- The university of Tokushima, emergency and critical care medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50000
Inclusion Criteria
Not provided
Exclusion Criteria
Insufficient information about body wight and height
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mortality (ICU, Hospital)
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link muscle mass to outcomes in ICU patients?
How does muscle mass measurement compare to traditional biomarkers in predicting mortality in septic shock patients?
What are the potential adverse events associated with muscle mass preservation strategies in critical care?
Are there specific drug targets that can enhance muscle mass in ICU patients with multi-organ failure?
How do current critical care protocols address muscle mass loss compared to emerging interventions in JPRN-UMIN000039754?